Novel Antibacterial Drugs
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 234
Special Issue Editors
Interests: medicinal chemistry; chemical biology; antiinflammation; antioxidant; antibacterial
Interests: protein misfolding; neuro-inflammation; peptide/protein therapeutics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bacterial infection presents a huge threat to human health. During the last few years, there has been continued progress in development of new treatment strategies of bacterial infection.
New agents including small molecules and peptides with antibacterial activities or improved therapies against bacterial infection have been reported. Targeting drugs specific to bacterial can minimize the toxic effects on mammalian cells.
This Special Issue on “The Antibacterial Drugs” aims to be an open forum where researchers may share their experiences and findings in this promising field. It is focused on the comprehensive and critical examination of current and emerging research on the design and development of advanced antibacterial agents and their application to experimental and clinical therapeutics.
Contributions to this issue, in the form of both original research and review articles, may cover all aspects of new discovery and development of new therapeutic agents for bacterial infections, especially small molecules and peptides
Prof. Dr. You-Zhi Tang
Dr. Haifan Wu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibacterial
- drug development
- pepitides
- bacterial resistance
- drug design
- synthesis
- plant derived compounds
- synergistic effects
